Strategies for responding to vaccine hesitancy and vaccine deniers

Sharpe, Abigail R.; Hayney, Mary S.

doi:10.1016/j.japh.2019.01.009

Cited by 5 publications

(4 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At a minimum, pharmacists can remind patients with each interaction that they are available to listen to their concerns, address their vaccine questions in plain language, and vaccinate when they feel ready. 42…”

Section: The Pharmacist's Role In Vaccine Confidencementioning

confidence: 99%

Exercising empathy: Pharmacists possess skills to increase coronavirus vaccine confidence

Akpoji¹,

Amos²,

McMillan³

et al. 2022

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

The coronavirus disease 2019 vaccines are the essential public health intervention to confer immunity against severe acute respiratory syndrome coronavirus 2, while decreasing the risks of severe COVID-19 disease, hospitalizations, and death associated with natural infection. Public health experts agree that the public health interventions of social distancing and face coverings will only be able to successfully curtail the COVID-19 pandemic in the United States when combined with the highly effective COVID-19 vaccines. The risk for severe COVID-19 is higher in Americans with highly prevalent metabolic and cardiovascular chronic conditions as well as vulnerable demographics, such as minorities and pregnant women. Unfortunately, experience with past unethical health practices can influence current vaccine confidence in people of color and women of childbearing age. Pharmacists are well-positioned in myriad health care settings across the nation to listen to these concerns and have the conversations necessary to increase vaccine confidence. Similar to effective roles that pharmacists have had in other health prevention efforts such as smoking cessation, pharmacists possess the motivational interviewing skills to guide patients from the "precontemplation" to the "action" stages of health behavior change. This nonjudgmental, mutual understanding will help identify the individual factors influencing vaccine decision-making and bring us closer to achieving "community immunity."Published by Elsevier Inc. on behalf of the American Pharmacists Association.

show abstract

Section: The Pharmacist's Role In Vaccine Confidencementioning

confidence: 99%

Exercising empathy: Pharmacists possess skills to increase coronavirus vaccine confidence

Akpoji¹,

Amos²,

McMillan³

et al. 2022

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

show abstract

“…Describe education to become an immunizing pharmacist and experience providing vaccines; Science: Summarize data on both the benefits and risks of vaccines; and Explain/Advise: Discuss strong belief in immunizations and that the benefits outweigh potential risks. 55…”

Section: Routine Adult Immunizations and Covid-19 Vaccinesmentioning

confidence: 99%

“…Given the language barrier among the newly settled Arabs in the US and the fact that myths may spread fast in close‐knit communities, many ARAM may simply be misinformed about the great benefits and the small risks associated with vaccines, especially new ones such as the COVID‐19 vaccines. One approach to address pseudo‐science and overcome vaccine hesitancy is to use the CASE method for speaking about vaccines: C orroborate: Connect emotionally with the patient by acknowledging concerns and respecting rationale; A bout Me: Describe education to become an immunizing pharmacist and experience providing vaccines; S cience: Summarize data on both the benefits and risks of vaccines; and E xplain/Advise: Discuss strong belief in immunizations and that the benefits outweigh potential risks 55 …”

Section: Routine Adult Immunizations and Covid‐19 Vaccinesmentioning

confidence: 99%

Culturally sensitive recommendations for the clinical pharmacist to engage the Arab American patient

Alosaimy

Mohammad

Chahine

et al. 2022

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Arab Americans (ARAM) comprise approximately 3.7 million individuals in the United States (US). The Census Bureau classifies ARAM as white and does not acknowledge them as a minority group in the Middle East North African (MENA) category creating a challenge when assessing their health outcomes. Like other minority groups, ARAM have unique social behaviors and cultural attributes that directly affect their health outcomes. However, many health care professionals in the US are not well‐informed of their culture. Hence, it is important for clinical pharmacists to familiarize themselves with the Arab culture in order to engage the ARAM patient and provide culturally competent care. This article reviews ARAM demographics and some of their common health behaviors and associated outcomes. The authors also offer culturally sensitive recommendations addressing important areas of health care to mitigate health disparities for this growing patient population.

show abstract

“…3 The threat of vaccine hesitancy persists despite significant clinical data supporting the benefit and importance of vaccinations in disease prevention. 4,5 In 2019, WHO classified vaccine hesitancy as a top 10 global health threat, alongside other major concerns such as the Ebola virus, HIV, and climate change. 6 Social media has contributed to this crisis by facilitating the promotion of information that is inaccurate, is not based in scientific evidence, or may increase patient uncertainty, anxiety, or hesitancy toward vaccination.…”

Section: Purposementioning

confidence: 99%

Extent of and Reasons for Vaccine Hesitancy in Adults at High-Risk for Pneumococcal Disease

et al. 2021

View full text Add to dashboard Cite

Purpose: To determine the extent of and reasons for hesitancy toward vaccination among adults at high-risk for pneumococcal disease. Design: Cross-sectional. Setting: Online survey in March-April 2019 via QuestionPro. Subjects: Tennessee adults (18-64 years) at high-risk of pneumococcal disease (n = 1,002). Measures: Modified version of the validated Vaccine Hesitancy Scale assessed vaccine-related beliefs, reasons for hesitancy, external influences on vaccination, and prior vaccination Analysis: Descriptive and inferential statistics provided an overview of the responses and comparisons among subgroups. Logistic regression determined the odds of being hesitant using the listed beliefs and influencers as predictors. Thematic analysis was performed on the qualitative data gathered from free response questions throughout the survey. Results: Analysis included 1,002 complete responses (12% response rate [total viewed = 8,331]) with 34.3% indicating hesitancy toward one or more recommended vaccinations, with 53% of which indicating hesitancy to the pneumococcal vaccine despite it being recommended by the Advisory Committee on Immunization Practices (ACIP) for all respondents. The odds of vaccine hesitancy or resistance were higher in minorities (OR: 1.6; 95% CI: 1.19-2.11), those not believing others like them get vaccinated (OR: 1.82; 95% CI: 1.262-2.613), and respondents recalling negative media about vaccines (OR: 2.56; 95% CI: 1.797-3.643). Conclusions: Patients at high-risk of pneumococcal disease lack awareness of the need for the recommended vaccine, and provider education may need improving to increase vaccination in this population.

show abstract

Strategies for responding to vaccine hesitancy and vaccine deniers

Cited by 5 publications

References 1 publication

Exercising empathy: Pharmacists possess skills to increase coronavirus vaccine confidence

Exercising empathy: Pharmacists possess skills to increase coronavirus vaccine confidence

Culturally sensitive recommendations for the clinical pharmacist to engage the Arab American patient

Extent of and Reasons for Vaccine Hesitancy in Adults at High-Risk for Pneumococcal Disease

Contact Info

Product

Resources

About